[Table 1](#pone.0139408.t001){ref-type="table"} has been corrected for improved readability. Please see the corrected [Table 1](#pone.0139408.t001){ref-type="table"} here.
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###### Clinical characteristics of the study subjects.
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  Study variable                                                                                   Value
  ------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------
  N (F)                                                                                            235 (19)
  Age, years[\*](#t001fn001){ref-type="table-fn"}                                                  40.97 (6.26)
  Framingham Risk Score[\*](#t001fn001){ref-type="table-fn"}                                       5.82 (5.11)
  W/H ratio[\*](#t001fn001){ref-type="table-fn"}                                                   0.94 (0.06)
  Overweight, n (%)                                                                                101 (42.97)
  Obesity, n (%)                                                                                   103 (43.83)
  Dyslipidemia, n (%)                                                                              120 (51.06)
  Diabetes mellitus, n (%)                                                                         7 (2.97)
  Hypertension, n (%)                                                                              104 (44.25)
  Stable CHD, n (%)                                                                                17 (7.23)
  Positive family history of CHD, n (%)                                                            128 (54.46)
  History of myocardial infarction, n (%)                                                          1 (0.42)
  PCI, n (%)                                                                                       5 (2.13)
  Smoking status, n (%)                                                                            
  Never, Current, Past, Pack-years[\*](#t001fn001){ref-type="table-fn"}                            96 (40.85), 79 (33.62), 60 (25.53), 17.68 (11.83)
  COPD, n (%)                                                                                      0
  Treatments, n (%)                                                                                
  Aspirin, ACEI/ARB, β-blocker, Ca-blocker, Diuretics, Lipid-lowering drugs, Anti diabetic drugs   8 (3.40), 44 (18.72), 42 (17.87), 14 (5.97), 30 (12.76), 13 (5.53), 7 (2.97)

\* Data are expressed as mean (SD); Framingham Risk Score, 10-year risk of developing coronary heart disease; W/H ratio, waist/hip; CHD, coronary heart disease; PCI, percutaneous coronary intervention; BMI, body mass index; ACEI, Angiotensin converting enzyme inhibitors; ARB, Angiotensin II receptor blockers; COPD, chronic obstructive pulmonary disease.

Obesity was defined as BMI\>30.0 kg/m^2^ and overweight as BMI \>25.0 kg/m^2^.

[Table 2](#pone.0139408.t002){ref-type="table"} has been corrected for improved readability. Please see the corrected [Table 2](#pone.0139408.t002){ref-type="table"} here.
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###### Characteristics of the study subjects stratified by metabolic syndrome status.
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  Study variable                                                              Metabolic Syndrome                   Non-Metabolic Syndrome               p value
  --------------------------------------------------------------------------- ------------------------------------ ------------------------------------ ------------------
  N (F)                                                                       109 (4)                              126 (15)                             0.038
  Age, years                                                                  42.54 (6.75)                         39.61 (5.48)                         \<0.001
  Framingham Risk Score                                                       8.32 (5.26)                          3.43 (2.99)                          \<0.0001
  BMI, kg/m^2^                                                                32.27 (3.73)                         27.78 (3.28)                         \<0.0001
  W/H ratio                                                                   0.98 (0.04)                          0.91(0.06)                           \<0.0001
  Systolic blood pressure, mm Hg                                              137.93 (16.93)                       124.15 (15.53)                       \<0.0001
  Diastolic blood pressure, mm Hg                                             87.66 (10.48)                        80.36 (9.79)                         \<0.0001
  Stable CHD, n (%)                                                           12 (11.01)                           5 (3.96)                             0.053
  Positive result of stress ECG; n (%)[\*](#t002fn002){ref-type="table-fn"}   18 (18.37)                           7 (6.60)                             0.012
  Coronary plaque burden, n (%)[\*\*](#t002fn003){ref-type="table-fn"}        29 (37.66)                           14 (18.18)                           0.007
  FMD, %                                                                      7.80 (3.23)                          8.17 (3.71)                          0.59
  IMT, mm                                                                     0.59 (0.10)                          0.54 (0.09)                          0.0002
  Smoking status, n (%)                                                                                                                                 
  Never, Current, Past                                                        35 (32.11), 40 (36.69), 34 (31.19)   61 (48.41), 39 (30.95), 26 (20.63)   0.01, 0.35, 0.06
  Total cholesterol, mmol/L                                                   5.61 (1.01)                          5.02 (0.88)                          \<0.0001
  LDL cholesterol, mmol/L                                                     3.25 (0.86)                          3.02 (0.76)                          0.056
  HDL cholesterol, mmol/L                                                     1.12 (0.25)                          1.37 (0.35)                          \<0.0001
  Triglycerides, mmol/L                                                       2.92 (1.76)                          1.35 (0.75)                          \<0.0001
  Glucose, mmol/L                                                             5.72 (1.29)                          5.08 (0.39)                          \<0.0001
  CRP, mg/L                                                                   2.18 (2.35)                          1.55 (1.78)                          0.0001
  TNF-α, pg/mL                                                                1.70 (2.85)                          1.25 (2.04)                          0.06

Data are expressed as mean (SD); BMI, body mass index; W/H, waist/hip; CHD, coronary heart disease; FMD, flow-mediated dilation; IMT, intima-media thickness; LDL, low density lipoprotein; HDL, high density lipoprotein; CRP, C-reactive protein; TNF-α, tissue necrotic factor-α;

\* n (%) subjects who underwent stress ECG;

\*\* n (%) subjects who underwent computed tomography coronary angiography.
